• Sinogastromyzon sichangensisis a hillstream loach endemic to the upper Yangtze River, China. It is unclear whether this fish lives in a very restricted area or may be dispersed over a long distance. In the present study spatial connectivity of populations of  sichangensis was investigated based on 343 individuals collected from 12 sites of Chishui River and employing 22 microsatellite loci.
• The results of genetic diversity analysis showed that observed heterozygosity (H_O) and polymorphism information content (PIC) ranged from 0.5653 to 0.6999 and 0.8513 to 0.8819, respectively. Population structure analysis suggested that  sichangensishad an unclear genetic structure. AMOVA showed that 69.36% of genetic variation was attributed to differentiation within individuals and all the pairwise genetic differentiation indices (F_ST) were low (mean F_ST = 0.0344), indicating weak differentiation among these populations.
• Estimation of gene flow showed frequent flow among populations, and contemporary levels (mean contemporary migration rate, m_c= 0.0131) were approximately equal to historical levels (mean historical migration rate, m_h = 0.0147).
• Individual relatedness analysis revealed a high level of sibship within and among different populations. The frequent gene flow and widespread sibship were due to  sichangensislaying drifting eggs which travel for a long distance until hatching, after which the juveniles or adults migrate upstream. The results of unclear geographic structure and frequent exchange also indicate that it is necessary to decrease the negative impacts of anthropogenic activities on the connectivity of rivers to protect the migration routes of S. sichangensis.

 

Case Report: Identification of a Novel Variant (m.8909T>C) of Human Mitochondrial ATP6 Gene and Its Functional Consequences on Yeast ATP Synthase

 

With the advent of next generation sequencing, the list of mitochondrial DNA (mtDNA) mutations identified in patients rapidly and continuously expands. They are frequently found in a limited number of cases, sometimes a single individual (as with the case herein reported) and in heterogeneous genetic backgrounds (heteroplasmy), which makes it difficult to conclude about their pathogenicity and functional consequences.

As an organism amenable to mitochondrial DNA manipulation, able to survive by fermentation to loss-of-function mtDNA mutations, and where heteroplasmy is unstable, Saccharomyces cerevisiae is an excellent model for investigating novel human mtDNA variants, in isolation and in a controlled genetic context. We herein report the identification of a novel variant in mitochondrial ATP6 gene, m.8909T>C. It was found in combination with the well-known pathogenic m.3243A>G mutation in mt-tRNA^Leu.

We show that an equivalent of the m.8909T>C mutation compromises yeast adenosine tri-phosphate (ATP) synthase assembly/stability and reduces the rate of mitochondrial ATP synthesis by 20-30% compared to wild type yeast. Other previously reported ATP6 mutations with a well-established pathogenicity (like m.8993T>C and m.9176T>C) were shown to have similar effects on yeast ATP synthase. It can be inferred that alone the m.8909T>C variant has the potential to compromise human health.

Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer

 

• Endometrial cancer (EC) is the commonest gynaecological malignancy. Current prognostic markers are inadequate to accurately predict patient survival, necessitating novel prognostic markers, to improve treatment strategies. Telomerase has a unique role within the endometrium, whilst aberrant telomerase activity is a hallmark of many cancers.
• The aim of the current in silico study is to investigate the role of telomere and telomerase associated genes and proteins (TTAGPs) in EC to identify potential prognostic markers and therapeutic targets. Analysis of RNA-seq data from The Cancer Genome Atlas identified differentially expressed genes (DEGs) in EC (568 TTAGPs out of 3467) and ascertained DEGs associated with histological subtypes, higher grade endometrioid tumours and late stage EC.
• Functional analysis demonstrated that DEGs were predominantly involved in cell cycle regulation, while the survival analysis identified 69 DEGs associated with prognosis. The protein-protein interaction network constructed facilitated the identification of hub genes, enriched transcription factor binding sites and drugs that may target the network.
• Thus, our in silico methods distinguished many critical genes associated with telomere maintenance that were previously unknown to contribute to EC carcinogenesis and prognosis, including NOP56, WFS1, ANAPC4and TUBB4A. Probing the prognostic and therapeutic utility of these novel TTAGP markers will form an exciting basis for future research.

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy

 

Cancer immunotherapy has been emerged as a promising strategy for treatment of a broad spectrum of malignancies ranging from hematological to solid tumors. One of the principal approaches of cancer immunotherapy is transfer of natural or engineered tumor-specific T-cells into patients,

a so called “adoptive cell transfer”, or ACT, process. Construction of allogeneic T-cells is dependent on the employment of a gene-editing tool to modify donor-extracted T-cells and prepare them to specifically act against tumor cells with enhanced function and durability and least side-effects. In this context, CRISPR technology can be used to produce universal T-cells, equipped with recombinant T cell receptor (TCR) or chimeric antigen receptor (CAR), through multiplex genome engineering using Cas nucleases.

The robust potential of CRISPR-Cas in preparing the building blocks of ACT immunotherapy has broaden the application of such therapies and some of them have gotten FDA approvals. Here, we have collected the last investigations in the field of immuno-oncology conducted in partnership with CRISPR technology. In addition, studies that have addressed the challenges in the path of CRISPR-mediated cancer immunotherapy, as well as pre-treatment applications of CRISPR-Cas have been mentioned in detail.

Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways

 

Background: Although the advances in diagnostic and treatment strategies, lung cancer remains the leading cause of cancer-related deaths, worldwide, with survival rates as low as 16% in developed countries. Low survival rates are mainly due to late diagnosis and the lack of effective treatment. Therefore, the identification of novel, clinically useful biomarkers is still needed for patients with advanced disease stage and poor survival.

Micro(mi)RNAs are non-coding RNAs and potent regulators of gene expression with a possible role as diagnostic, prognostic and predictive biomarkers in cancer.

Methods: We applied global miRNA expression profiling analysis using TaqMan^® arrays in paired tumor and normal lung tissues (n = 38) from treatment-naïve patients with lung adenocarcinoma (AD; n = 23) and lung squamous cell carcinoma (SCC; n = 15). miRNA target genes were validated using The Cancer Genome Atlas (TCGA) lung AD (n = 561) and lung SCC (n = 523) RNA-Seq datasets.

Results: We identified 33 significantly deregulated miRNAs (fold change, FC ≥ 2.0 and p < 0.05) in tumors relative to normal lung tissues, regardless of tumor histology. Enrichment analysis confirmed that genes targeted by the 33 miRNAs are aberrantly expressed in lung AD and SCC, and modulate known pathways in lung cancer. Additionally, high expression of miR-25-3p was significantly associated (p < 0.05) with poor patient survival, when considering both tumor histologies.

Conclusions: miR-25-3p may be a potential prognostic biomarker in non-small cell lung cancer. Genes targeted by miRNAs regulate EGFR and TGFβ signaling, among other known pathways relevant to lung tumorigenesis.

 

FOS-B Human Recombinant Protein
PROTP53539	BosterBio	Regular: 5ug	EUR 574.8
Description: FOS-B Human Recombinant (a.a. 113-151) expressed in E.coli, shows a 32 kDa SDS-PAGE (Including GST).;The FOS-B is purified by proprietary chromatographic techniques.

Recombinant (E.Coli, GST) Human FOS-B
RP-945	Alpha Diagnostics	2 ug	EUR 416.4

FOS B antibody
29246-100ul	SAB	100ul	EUR 302.4

Fos B Rabbit pAb
E2381043	EnoGene	100ul	EUR 225
Description: Available in various conjugation types.

Fos B Rabbit mAb
A24339	Abclonal	200μL	EUR 323.7
Description: A synthetic peptide corresponding to a sequence within amino acids 371-470 of human Desmin (P17661).

FOS B Conjugated Antibody
C29246	SAB	100ul	EUR 476.4

Fos B Polyclonal Antibody
ABP51360-003ml	Abbkine	0.03ml	EUR 189.6
Description: A polyclonal antibody for detection of Fos B from Human, Mouse, Monkey. This Fos B antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the non-phosphorylation site of S27

Fos B Polyclonal Antibody
ABP51360-01ml	Abbkine	0.1ml	EUR 346.8
Description: A polyclonal antibody for detection of Fos B from Human, Mouse, Monkey. This Fos B antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the non-phosphorylation site of S27

Fos B Polyclonal Antibody
ABP51360-02ml	Abbkine	0.2ml	EUR 496.8
Description: A polyclonal antibody for detection of Fos B from Human, Mouse, Monkey. This Fos B antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the non-phosphorylation site of S27

Fos B Polyclonal Antibody
ES2359-100ul	ELK Biotech	100ul	EUR 334.8
Description: A Rabbit Polyclonal antibody against Fos B from Human/Mouse/Monkey. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Fos B Polyclonal Antibody
ES2359-50ul	ELK Biotech	50ul	EUR 248.4
Description: A Rabbit Polyclonal antibody against Fos B from Human/Mouse/Monkey. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Fos B Polyclonal Antibody
E20-71738	EnoGene	100ug	EUR 225
Description: Available in various conjugation types.

Human Proto- oncogene c- Fos, FOS ELISA KIT
ELI-04266h	Lifescience Market	96 Tests	EUR 988.8

Recombinant Human FOS-B Protein, Untagged, E.coli-2ug
QP11898-2ug	EnQuireBio	2ug	EUR 294

Recombinant Human FOS-B Protein, Untagged, E.coli-5ug
QP11898-5ug	EnQuireBio	5ug	EUR 403.2

Recombinant Human FOS-B Protein, Untagged, E.coli-10ug
QP11898-10ug	EnQuireBio	10ug	EUR 663.6

Anti-Fos B/FOSB Antibody
PA1478	BosterBio	100ug/vial	EUR 352.8

Anti-Fos B/FOSB Antibody
RP1086	BosterBio	100ug/vial	EUR 400.8

Human FOS ELISA Kit
ELA-E1291h	Lifescience Market	96 Tests	EUR 988.8

FOS ELISA KIT|Human
EF005100	Lifescience Market	96 Tests	EUR 826.8

Human FOS ELISA Kit
EHF0120	Abclonal	96Tests	EUR 625.2

Human FOS ELISA Kit
IHUFOSKT	Innovative research	each	EUR 548
Description: Human FOS ELISA Kit

Human Proto-Oncogene C-Fos (FOS) CLIA Kit
20-abx492601	Abbexa	EUR 9567.60 EUR 5095.20 EUR 1177.20	10 × 96 tests 5 × 96 tests 96 tests

Human Proto-Oncogene C-Fos (FOS) ELISA Kit
20-abx151580	Abbexa	EUR 8534.40 EUR 4550.40 EUR 1054.80	10 × 96 tests 5 × 96 tests 96 tests

Human Proto-oncogene c-Fos (FOS) ELISA Kit
abx570165-96tests	Abbexa	96 tests	EUR 801.6

Human FOS/ Proto-oncogene c-Fos ELISA Kit
E0936Hu	Sunlong	1 Kit	EUR 685.2

Human FOS(Proto-oncogene c-Fos) ELISA Kit
EH1465	FN Test	96T	EUR 681.12
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml

Human Proto-oncogene c-Fos (FOS) ELISA Kit
RK07956	Abclonal	96T	EUR 280

Human FOS(Proto-oncogene c-Fos) ELISA Kit
EKF58552-48T	Biomatik Corporation	48T	EUR 396.9

Human FOS(Proto-oncogene c-Fos) ELISA Kit
EKF58552-5x96T	Biomatik Corporation	5x96T	EUR 2693.25

Human FOS(Proto-oncogene c-Fos) ELISA Kit
EKF58552-96T	Biomatik Corporation	96T	EUR 567

Human FOS shRNA Plasmid
20-abx951644	Abbexa	EUR 961.20 EUR 1345.20	150 µg 300 µg

FOS Recombinant Protein (Human)
RP012430	ABM	100 ug	Ask for price

Human c Fos ELISA kit
E01C0735-192T	BlueGene	192 tests	EUR 1524
Description: A competitive ELISA for quantitative measurement of Human c Fos in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human c Fos ELISA kit
E01C0735-48	BlueGene	1 plate of 48 wells	EUR 624
Description: A competitive ELISA for quantitative measurement of Human c Fos in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human c Fos ELISA kit
E01C0735-96	BlueGene	1 plate of 96 wells	EUR 822
Description: A competitive ELISA for quantitative measurement of Human c Fos in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

FOS ORF Vector (Human) (pORF)
ORF004144	ABM	1.0 ug DNA	EUR 114

Fos B (phospho Ser27) Polyclonal Antibody
ABP54356-003ml	Abbkine	0.03ml	EUR 189.6
Description: A polyclonal antibody for detection of Fos B phospho Ser27) from Human, Mouse. This Fos B phospho Ser27) antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the phosphorylation site of S27

Fos B (phospho Ser27) Polyclonal Antibody
ABP54356-01ml	Abbkine	0.1ml	EUR 346.8
Description: A polyclonal antibody for detection of Fos B phospho Ser27) from Human, Mouse. This Fos B phospho Ser27) antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the phosphorylation site of S27

Fos B (phospho Ser27) Polyclonal Antibody
ABP54356-02ml	Abbkine	0.2ml	EUR 496.8
Description: A polyclonal antibody for detection of Fos B phospho Ser27) from Human, Mouse. This Fos B phospho Ser27) antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the phosphorylation site of S27

Fos B (phospho Ser27) Polyclonal Antibody
ES5355-100ul	ELK Biotech	100ul	EUR 334.8
Description: A Rabbit Polyclonal antibody against Fos B (phospho Ser27) from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Fos B (phospho Ser27) Polyclonal Antibody
ES5355-50ul	ELK Biotech	50ul	EUR 248.4
Description: A Rabbit Polyclonal antibody against Fos B (phospho Ser27) from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Fos B (phospho Ser27) Polyclonal Antibody
E20-61178	EnoGene	100ug	EUR 225
Description: Available in various conjugation types.

Fos B (phospho Ser27) Polyclonal Antibody
E013857	EnoGene	100μg/100μl	EUR 255
Description: Available in various conjugation types.

FOS ELISA Kit (Human) (OKDD00273)
OKDD00273	Aviva Systems Biology	96 Wells	EUR 1107.6
Description: Description of target: The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. In some cases, expression of the FOS gene has also been associated with apoptotic cell death.;Species reactivity: Human;Application: ;Assay info: Quantitative Sandwich ELISA;Sensitivity: < 0.064 ng/mL

FOS ELISA Kit (Human) (OKCD07290)
OKCD07290	Aviva Systems Biology	96 Wells	EUR 1123.2
Description: Description of target: The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. In some cases, expression of the FOS gene has also been associated with apoptotic cell death.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.054ng/mL

FOS ELISA Kit (Human) (OKEH04574)
OKEH04574	Aviva Systems Biology	96 Wells	EUR 1216.8
Description: Description of target: The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. In some cases, expression of the FOS gene has also been associated with apoptotic cell death.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.12 ng/mL

Human FOS Protein Lysate 20ug
IHUFOSPLLY20UG	Innovative research	each	EUR 213
Description: Human FOS Protein Lysate 20ug

Human Fos-related antigen 2 (FOSL2)
1-CSB-EP008793HU	Cusabio	EUR 456.00 EUR 256.80 EUR 1570.80 EUR 672.00 EUR 1047.60 EUR 314.40	100ug 10ug 1MG 200ug 500ug 50ug
Description: Recombinant Human Fos-related antigen 2(FOSL2) expressed in E.coli

anti-Fos B
YF-PA23732	Abfrontier	50 ul	EUR 400.8
Description: Mouse polyclonal to Fos B

anti-Fos B
YF-PA11841	Abfrontier	50 ul	EUR 435.6
Description: Mouse polyclonal to Fos B

anti-Fos B
YF-PA11842	Abfrontier	50 ug	EUR 435.6
Description: Mouse polyclonal to Fos B

anti-Fos B
YF-PA11843	Abfrontier	100 ul	EUR 483.6
Description: Rabbit polyclonal to Fos B

anti-Fos B
YF-PA11844	Abfrontier	100 ug	EUR 483.6
Description: Rabbit polyclonal to Fos B

Human FOS Like Antigen 1 (FOSL1) Protein
20-abx066690	Abbexa	EUR 878.40 EUR 343.20 EUR 2732.40 EUR 1045.20 EUR 627.60	100 ug 10 ug 1 mg 200 ug 50 ug

FOS sgRNA CRISPR Lentivector set (Human)
K0794201	ABM	3 x 1.0 ug	EUR 406.8

FOS siRNA
20-abx917079	Abbexa	EUR 661.20 EUR 878.40	15 nmol 30 nmol

FOS siRNA
20-abx917080	Abbexa	EUR 661.20 EUR 878.40	15 nmol 30 nmol

FOS siRNA
20-abx902000	Abbexa	EUR 661.20 EUR 878.40	15 nmol 30 nmol

Human V-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS) Protein
20-abx166659	Abbexa	EUR 794.40 EUR 326.40 EUR 2448.00 EUR 944.40 EUR 577.20	100 ug 10 ug 1 mg 200 ug 50 ug

Human FOS Like Antigen 1 (FOSL1) ELISA Kit
abx384927-96tests	Abbexa	96 tests	EUR 1093.2

Human FOS Like Antigen 2 (FOSL2) ELISA Kit
abx387396-96tests	Abbexa	96 tests	EUR 1093.2

Human FOS-like antigen 2 (fosl2) ELISA Kit
YLA3890HU-48T	Shanghai YL Biotech	48T	EUR 435

Human FOS-like antigen 2 (fosl2) ELISA Kit
YLA3890HU-96T	Shanghai YL Biotech	96T	EUR 562.5

FOS antibody
10R-1389	Fitzgerald	100 ug	EUR 614.4
Description: Mouse monoclonal FOS antibody

FOS Antibody
29093-100ul	SAB	100ul	EUR 302.4

Fos antibody
70R-31126	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal Fos antibody

FOS antibody
70R-31287	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal FOS antibody

FOS antibody
70R-34384	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal FOS antibody

FOS antibody
70R-34398	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal FOS antibody

Fos antibody
70R-34513	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal Fos antibody

Fos Antibody
33336-100ul	SAB	100ul	EUR 302.4

Fos Antibody
33336-50ul	SAB	50ul	EUR 224.4

FOS Antibody
32032-100ul	SAB	100ul	EUR 302.4

FOS Antibody
ABD6039	Lifescience Market	100 ug	EUR 525.6

Fos Antibody
ABF0132	Lifescience Market	100 ug	EUR 525.6

Fos Antibody
ABF5354	Lifescience Market	100 ug	EUR 525.6

Fos Antibody
ABF6053	Lifescience Market	100 ug	EUR 525.6

FOS Antibody
CSB-PA138717-	Cusabio	each	EUR 402
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

FOS Antibody
CSB-PA138717-100ul	Cusabio	100ul	EUR 376.8
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

FOS Antibody
CSB-PA042478-	Cusabio	each	EUR 402
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000

FOS Antibody
CSB-PA042478-100ul	Cusabio	100ul	EUR 379.2
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000

FOS Antibody
1-CSB-PA191502	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:50-1:200

FOS Antibody
CSB-PA292648-	Cusabio	each	EUR 402
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100

FOS Antibody
CSB-PA292648-100ul	Cusabio	100ul	EUR 379.2
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100

FOS Antibody
1-CSB-PA008385	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

FOS Antibody
CSB-PA008790KA01HU-	Cusabio	each	EUR 402
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

FOS Antibody
CSB-PA008790KA01HU-100ul	Cusabio	100ul	EUR 466.8
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

FOS Antibody
1-CSB-PA000378	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB;WB:1:1000-2000

FOS Antibody
1-CSB-PA001600	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000